NASDAQ: HROW, HROWL, HROWM

Harrow Health, Inc.

罗森律师事务所宣布一项代表Harrow Health, Inc. (NASDAQ: HROW; HROWL; HROWM) 的投资人对该公司潜在的集体诉讼请求发起调查。该调查缘起于对Harrow 可能向投资公众发布了具有重大误导性的商业信息的指控。

如果您购买了Harrow 股票,并且您想参加此次集体诉讼的话,请点击“加入此集体行动”键。

如果您购买了 Harrow 证券,您可能有权获得赔偿,而无需支付任何自付费用或通过应急费用安排产生的费用。

Details of the case:

2023 年 2 月 22 日,市场分析家 Bonitas Research 发表了一份关于 Harrow 的报告。其中该报告称,Harrow 隐瞒了美国司法部(「DOJ」)对其销售行为的调查,与前子公司进行可疑交易,以牺牲股东利益为代价为公司内部人员牟利,并从事低于标准的商业行为,致使美国食品和药物监督管理局(「FDA」)发出了一系列警告。

受此消息影响,Harrow 的股价在盘中交易中较前收盘价下跌了 10%。

Follow us on:

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top